In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
Oklahoma Medical Research Foundation | OMRF
OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.
